Biomarker for monitoring patients
OwnerBruce Acresinventor
Life of this patent
Estimating the term…
Abstract
The present invention is in the field of immunotherapy and relates to methods for determining the efficacy of certain immunotherapy treatments. The methods of the invention include measuring special biomarker at some time following the initiation of immunotherapy treatment to evaluate the clinical outcome of the said treatment. The invention thus has applications to the field of medicine.
Claims11
A method for assessing the efficacy of a treatment comprising the administration of an immunogenic composition to a patient, the method comprising:
- administering one or more doses of said immunogenic composition to said patient;
- and
- measuring the level of activated T lymphocytes CD3+ and CD69+ in the body of said patient ex vivo following administration of at least one of said doses.
A method for assessing the efficacy of a treatment comprising the administration of an immunogenic composition to a patient, the method comprising:
- administering one or more doses of said immunogenic composition to said patient;
- and
- measuring the level of activated T lymphocytes CD3+ and CD69+ in the body of said patient ex vivo following administration of at least one of said doses,
- wherein a level of activated T lymphocytes CD3+ and CD69+ above about 10.4% indicates a successful clinical outcome for the treatment.
Dependencies are inferred from the claim text.